RecruitingPhase 4NCT07459049

"Effect of Ibuprofen on Acute Inflammatory Response After One-Stage Periodontal Therapy"

Efficacy Of Ibuprofen In Reducing Acute Inflammatory Response Following One Stage Non- Surgical Periodontal Therapy (A Randomized Clinical Trial )


Sponsor

University of Baghdad

Enrollment

30 participants

Start Date

Dec 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this ( Clinical Trial ) is to evaluate the efficacy of Ibuprofen in reducing acute inflammatory response (hs-CRP, ProCT, IL-6) after one hour and one week following one stage non surgical periodontal therapy. The main question it aims to answer is: "Does Ibuprofen effectively reduce the acute inflammatory response ( hs-CRP, ProCT, IL-6) following one-stage non-surgical periodontal therapy?"


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • systemically healthy patients.
  • having a minimum of 20 teeth.
  • Generalized unstable periodontitis.
  • Pocket depth \[≥ 4 mm\].
  • All included participants should be adults aged more than 18 years .
  • smokers and non smokers

Exclusion Criteria12

  • Allergy or hypersensitivity to Ibuprofen or other NSAIDs.
  • current systemic anti-inflammatory or antibiotic therapy (\<3 months).
  • peptic ulcer disease.
  • recent periodontal therapy (\<3 months).
  • Asthma.
  • Renal impairment .
  • Hepatic impairment.
  • Severe cardiac disease (heart failure, hypertension (.
  • Bleeding disorders (e.g., hemophilia) or patients taking anticoagulants .
  • Any participant who had known or suspected high risk for tuberculosis, hepatitis B or HIV infections.
  • pregnant or lactating females.
  • those being unable to provide written informed consent.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURENon surgical root surface debridement in one stage without receiving Ibuprofen

Control group: After one week from baseline visit which include supragingival debridement by using ultrasonic device . sites will receive root surface debridement (RSD) using area specific (Gracey) curettes (Medesy, Italy). Without receiving Ibuprofen.

DRUGNon surgical root surface debridement in one stage with receiving Ibuprofen

Test group: After one week from baseline visit which include supragingival debridement by using ultrasonic device . Test group will receive first dose of Ibuprofen (400 mg) administer one hour before root surface debridement and the subsequent doses will be taken 3 times daily for a duration of 3 days after RSD.


Locations(1)

College of Dentistry, University of Baghdad

Baghdad, Iraq

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07459049


Related Trials